• Hep B PAST partnership 
• PROLIFICA - NT  
• BAMBI
• Galiwin’ku sero-survey – Establishing the size of the problem in Galiwin’ku – “Know your Hep B Status”  
• A novel Hepatitis B virus genotype in Indigenous Australians: impact on vaccine efficacy and clinical outcomes – a data linkage study 
• The Changing Epidemiology of Hepatitis B in the Northern Territory 
• Hepatitis B in the Top End of the Northern Territory: health literacy among those affected and innovative ways to improve it 
• Looking into influenza T cell immunity - LIFT
• CAMERA2 Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus Aureus infection.
• CHARM - Characterising Hepatitis B in northern Australia through molecular epidemiology

1. Davies, J., Li, S. Q., Tong, S. Y., Baird, R. W., Beaman, M., Higgins, G., Cowie, B. C., Condon, J. R., & Davis, J. S. (2017). Establishing contemporary trends in hepatitis B sero-epidemiology in an Indigenous population. PLOS ONE, 12(9), e0184082. https://doi.org/10.1371/journal.pone.0184082 
2. Davies, J., Smith, E. L., Littlejohn, M., Edwards, R., Sozzi, V., Jackson, K., McGuire, K., Binks, P., Cowie, B., Locarnini, S., Davis, J. S., & Tong, S. Y. C. (2019). Towards genotype-specific care for chronic hepatitis B: The first 6 years of follow up from the CHARM cohort study. Open Forum Infectious Diseases, 6(11), ofz469. https://doi.org/10.1093/ofid/ofz469 
3. Hla, T. K., Bukulatjpi, S., Binks, P., Gurruwiwi, G. G., Dhurrkay, R. G., & Davies, J. (2020). A one stop liver shop approach improves the cascade of care for Aboriginal people: Results of a novel care delivery model. International Journal for Equity in Health, 19(1), 64. https://doi.org/10.1186/s12939-020-01180-w 
4. Hosking, K., Stewart, G., Mobsby, M., Skov, S., Zhao, Y., Su, J., Tong, S., Nihill, P., Davis, J., Connors, C., & Davies, J. (2020). Data linkage and computerized algorithmic coding to enhance individual clinical care for Aboriginal people living with chronic hepatitis B in the Northern Territory of Australia: Is it feasible? PLOS ONE, 15(4), e0232207. https://doi.org/10.1371/journal.pone.0232207 
5. Hosking, K., Binks, P., de Santis, T., … Davis, J. S., Connors, C., & Davies, J., on behalf of the Hep B PAST Partnership. (2024). Evaluating a novel model of hepatitis B care, Hep B PAST, in the Northern Territory of Australia: Results from a prospective, population-based study. The Lancet Regional Health – Western Pacific, 48, 101116. https://doi.org/10.1016/j.lanwpc.2024.101116
6. Hosking, K., de Santis, T., Vintour-Cesar, E., Wilson, P. M., Bunn, L., Gurruwiwi, G. G., Wurrawilya, S., Bukulatjpi, S. M., Nelson, S., Ross, C., Binks, P., Schroder, P., Davis, J. S., Taylor, S., Connors, C., & Davies, J. (2023). “The most culturally safe training I’ve ever had”: The co-design of a culturally safe managing hepatitis B training course with and for the Aboriginal health workforce of the Northern Territory of Australia. BMC Health Services Research, 23(1), 935. https://doi.org/10.21203/rs.3.rs-2830413/v1
7. Howell, J., Seaman, C., Wallace, J., Xiao, Y., Scott, N., Davies, J., de Santis, T., Adda, D., El-Sayed, M., Feld, J., Gane, E., Lacombe, K., Lesi, O., Mohamed, R., Silva, M., Tu, T., Revill, P., & Hellard, M. (2023). Pathway to global elimination of hepatitis B: HBV cure is just the first step. Hepatology, 78(3), 976–990. https://doi.org/10.1097/HEP.0000000000000430 
8. Martin, G. E., Hosking, K., Banz, K., Gargan, C., Stewart, G., Greenwood-Smith, B., Ramsey, P., Tate-Baker, J., Connors, C., Binks, P., McKinnon, M., Manchikanti, P., Gurruwiwi, G. G., … Fuller, K., Tong, S. Y. C., Boettiger, D., Cowie, B., Davis, J. S., Bukulatjpi, S. M., & Davies, J. (2025). Disease progression and treatment need in sub-genotype C4 hepatitis B infection: A retrospective cohort study in the Northern Territory, Australia. BMC Infectious Diseases, 25(1), 881. https://doi.org/10.1186/s12879-025-11213-w
9. Tong, S. Y. C., Lye, D. C., Yahav, D., Sud, A., Robinson, J. O., Nelson, J., Archuleta, S., Roberts, M. A., Cass, A., Paterson, D., … Davies, J., … O’Sullivan, M. V. N., & Davis, J. S. (2020). Effect of vancomycin or daptomycin with vs without an antistaphylococcal β-lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA bacteremia: A randomized clinical trial. Journal of the American Medical Association, 323(6). https://doi.org/10.1001/jama.2020.0103
10. Zhang, W., Kedzierski, L., Chua, B., Mayo, M., Lonzi, C., Rigas, V., Middleton, B., McQuilten, H., Rowntree, L., Allen, L., … Nguyen, T. H. O., Davies, J., & Kedzierska, K. (2023). Robust and prototypical immune responses toward COVID-19 vaccine in First Nations peoples are impacted by comorbidities. Nature Immunology, 24(6), 966–978. https://doi.org/10.1038/s41590-023-01508-y 

Click here to view more Jane Davies publications in PubMed.